276 related articles for article (PubMed ID: 35077567)
1. [Fatal opioid overdoses usually occur without anyone being present and able to intervene. Knowledge of the presence of witnesses is important for how naloxone programs should be designed].
Andersson L; Johnson B
Lakartidningen; 2022 Jan; 119():. PubMed ID: 35077567
[TBL] [Abstract][Full Text] [Related]
2. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
3. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
4. The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees.
Argenyi MS; Evans JK; Gay Y; Epstein DH; Weiss ST
Clin Toxicol (Phila); 2023 Jul; 61(7):509-517. PubMed ID: 37427894
[TBL] [Abstract][Full Text] [Related]
5. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
6. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
7. Take-home Naloxone at Opioid Treatment Programs: A Lifesaver.
Katzman JG; Bhatt S; Comerci GD
J Addict Med; 2022 Nov-Dec 01; 16(6):619-621. PubMed ID: 35220332
[TBL] [Abstract][Full Text] [Related]
8. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
[TBL] [Abstract][Full Text] [Related]
9. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
[TBL] [Abstract][Full Text] [Related]
10. [First Aid Training for Drug Overdose in Opioid Addicts and Provision of Take-Home Naloxone on Release from Prison: Feasibility Study from the Bavarian Model Project].
Wodarz-von Essen HJ; Wolstein J; Pogarell O; Wodarz N
Gesundheitswesen; 2023 Jun; 85(6):568-572. PubMed ID: 36126950
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS; Williams AV
Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Naloxone for Opioid Overdose.
Taylor JL; Lasser KE
JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement.
Zang X; Skinner A; Krieger MS; Behrends CN; Park JN; Green TC; Walley AY; Morgan JR; Linas BP; Yedinak JL; Schackman BR; Marshall BDL
JAMA Netw Open; 2024 May; 7(5):e2413861. PubMed ID: 38814644
[TBL] [Abstract][Full Text] [Related]
14. Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden.
Troberg K; Isendahl P; Blomé MA; Dahlman D; Håkansson A
BMC Psychiatry; 2020 Feb; 20(1):49. PubMed ID: 32028921
[TBL] [Abstract][Full Text] [Related]
15. Naloxone Knowledge and Attitudes of Juvenile Residents in a Detention Setting.
Hammond A; Obrecht J; Odunuyi O; Magloire P; Walsh S
J Correct Health Care; 2022 Jun; 28(3):148-154. PubMed ID: 35263179
[TBL] [Abstract][Full Text] [Related]
16. Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis.
Taylor M; Pradhan A; Ogando YM; Shaya F
Am J Drug Alcohol Abuse; 2022 May; 48(3):338-346. PubMed ID: 35467459
[No Abstract] [Full Text] [Related]
17. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
[TBL] [Abstract][Full Text] [Related]
18. Naloxone for Opioid Overdose: Comment.
Milas BL; Varon AJ
Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
[No Abstract] [Full Text] [Related]
19. Naloxone for Opioid Overdose: Comment.
Pattullo GG
Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
[No Abstract] [Full Text] [Related]
20. Concentrations of psychoactive substances in blood samples from non-fatal and fatal opioid overdoses.
Edvardsen HME; Aamodt C; Bogstrand ST; Krajci P; Vindenes V; Rognli EB
Br J Clin Pharmacol; 2022 Oct; 88(10):4494-4504. PubMed ID: 35470456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
